Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 390

1.

Towards a European health research and innovation cloud (HRIC).

Aarestrup FM, Albeyatti A, Armitage WJ, Auffray C, Augello L, Balling R, Benhabiles N, Bertolini G, Bjaalie JG, Black M, Blomberg N, Bogaert P, Bubak M, Claerhout B, Clarke L, De Meulder B, D'Errico G, Di Meglio A, Forgo N, Gans-Combe C, Gray AE, Gut I, Gyllenberg A, Hemmrich-Stanisak G, Hjorth L, Ioannidis Y, Jarmalaite S, Kel A, Kherif F, Korbel JO, Larue C, Laszlo M, Maas A, Magalhaes L, Manneh-Vangramberen I, Morley-Fletcher E, Ohmann C, Oksvold P, Oxtoby NP, Perseil I, Pezoulas V, Riess O, Riper H, Roca J, Rosenstiel P, Sabatier P, Sanz F, Tayeb M, Thomassen G, Van Bussel J, Van den Bulcke M, Van Oyen H.

Genome Med. 2020 Feb 19;12(1):18. doi: 10.1186/s13073-020-0713-z.

2.

Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.

Kjær M, Geisen C, Akkök ÇA, Wikman A, Sachs U, Bussel JB, Nielsen K, Walles K, Curtis BR, Vidarsson G, Järås K, Skogen B.

Transfus Apher Sci. 2019 Dec 31:102712. doi: 10.1016/j.transci.2019.102712. [Epub ahead of print] Review.

3.

Long-term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP).

Lee EJ, Izak M, Bussel JB.

Br J Haematol. 2020 Jan 3. doi: 10.1111/bjh.16328. [Epub ahead of print]

PMID:
31900937
4.

Mechanisms and therapeutic prospects of thrombopoietin receptor agonists.

Bussel J, Kulasekararaj A, Cooper N, Verma A, Steidl U, Semple JW, Will B.

Semin Hematol. 2019 Oct;56(4):262-278. doi: 10.1053/j.seminhematol.2019.09.001. Epub 2019 Oct 19. Review.

PMID:
31836033
5.

Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists.

Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM.

Thromb Res. 2020 Jan;185:119-124. doi: 10.1016/j.thromres.2019.11.031. Epub 2019 Nov 30.

6.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ.

Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.

7.

Identifying and Treating Refractory ITP: Difficulty in Diagnosis and Role of Combination Treatment.

Miltiadous O, Hou M, Bussel JB.

Blood. 2019 Nov 22. pii: blood.2019003599. doi: 10.1182/blood.2019003599. [Epub ahead of print]

PMID:
31756253
8.

Peri- and Postpartum Management of Patients With Factor XI Deficiency.

Gerber GF, Klute KA, Chapin J, Bussel J, DeSancho MT.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619880262. doi: 10.1177/1076029619880262.

9.

Blood transcriptome and clonal T cell correlates of response and nonresponse to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia.

Zhang H, Zhang BM, Guo X, Xu L, You X, West RB, Bussel JB, Zehnder JL.

Haematologica. 2019 Jul 11. pii: haematol.2019.226688. doi: 10.3324/haematol.2019.226688. [Epub ahead of print]

10.

Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists.

Garabet L, Ghanima W, Hellum M, Sandset PM, Bussel JB, Tran H, Henriksson CE.

Platelets. 2019 Jul 7:1-7. doi: 10.1080/09537104.2019.1639655. [Epub ahead of print]

PMID:
31280643
11.

FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency.

Vandrovcova J, Salzer U, Grimbacher B, Wanders J, Rao K, Thrasher A, Burns S, Gilmore K, Bussel J, Cooper N.

Br J Haematol. 2019 Sep;186(6):e163-e165. doi: 10.1111/bjh.15979. Epub 2019 Jun 6. No abstract available.

PMID:
31172514
12.

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Lucchini E, Zaja F, Bussel J.

Haematologica. 2019 Jun;104(6):1124-1135. doi: 10.3324/haematol.2019.218883. Epub 2019 May 24. Review.

13.

Thrombopoietin receptor agonists: ten years later.

Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB.

Haematologica. 2019 Jun;104(6):1112-1123. doi: 10.3324/haematol.2018.212845. Epub 2019 May 9. Review.

14.

Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia.

Jin JC, Lakkaraja MM, Ferd P, Manotas K, Gabor J, Wissert M, Berkowitz RL, McFarland JG, Bussel JB.

Am J Hematol. 2019 Aug;94(8):E213-E215. doi: 10.1002/ajh.25503. Epub 2019 May 16. No abstract available.

PMID:
31056760
15.

Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia.

Hogan M, Geyer JT, Bussel JB.

Am J Hematol. 2019 Jul;94(7):E196-E198. doi: 10.1002/ajh.25496. Epub 2019 May 3. No abstract available.

PMID:
31012979
16.

Postnatal intervention for the treatment of FNAIT: a systematic review.

Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

J Perinatol. 2019 Oct;39(10):1329-1339. doi: 10.1038/s41372-019-0360-7. Epub 2019 Apr 10. Review.

PMID:
30971767
17.

Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM.

Am J Hematol. 2019 Jul;94(7):741-750. doi: 10.1002/ajh.25479. Epub 2019 Apr 29.

PMID:
30945320
18.

Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.

Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM.

Platelets. 2020;31(2):198-205. doi: 10.1080/09537104.2019.1585527. Epub 2019 Mar 18.

PMID:
30885035
19.

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.

Tarantino MD, Bussel JB, Blanchette VS, Beam D, Roy J, Despotovic J, Raj A, Carpenter N, Mehta B, Eisen M.

Haematologica. 2019 Nov;104(11):2283-2291. doi: 10.3324/haematol.2018.202283. Epub 2019 Mar 7.

20.

Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.

Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Kjaer M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia H, Landry D, Shehata N; International Collaboration for Transfusion Medicine Guidelines (ICTMG).

Br J Haematol. 2019 May;185(3):549-562. doi: 10.1111/bjh.15813. Epub 2019 Mar 3.

PMID:
30828796
21.

Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.

Bussel JB, Arnold DM, Boxer MA, Cooper N, Mayer J, Zayed H, Tong S, Duliege AM.

Am J Hematol. 2019 May;94(5):546-553. doi: 10.1002/ajh.25444. Epub 2019 Mar 13.

22.

Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study.

Grainger JD, Blanchette VS, Grotzinger KM, Roy A, Bussel JB.

Br J Haematol. 2019 Apr;185(1):102-106. doi: 10.1111/bjh.15732. Epub 2018 Dec 27.

PMID:
30592022
23.

Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.

Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J; International Collaboration for Transfusion Medicine Guidelines.

Vox Sang. 2019 Jan;114(1):79-94. doi: 10.1111/vox.12725. Epub 2018 Nov 22.

PMID:
30565711
24.

Platelet transfusion practices in immune thrombocytopenia related hospitalizations.

Goel R, Chopra S, Tobian AAR, Ness PM, Frank SM, Cushing M, Vasovic L, Kaicker S, Takemoto C, Josephson CD, Nellis M, Bussel J, Krishnamurti L.

Transfusion. 2019 Jan;59(1):169-176. doi: 10.1111/trf.15069. Epub 2018 Dec 5.

PMID:
30520045
25.

Health Data for Research Through a Nationwide Privacy-Proof System in Belgium: Design and Implementation.

Delvaux N, Aertgeerts B, van Bussel JC, Goderis G, Vaes B, Vermandere M.

JMIR Med Inform. 2018 Nov 19;6(4):e11428. doi: 10.2196/11428.

26.

Health-related quality of life in adult primary immune thrombocytopenia.

Sestøl HG, Trangbæk SM, Bussel JB, Frederiksen H.

Expert Rev Hematol. 2018 Dec;11(12):975-985. doi: 10.1080/17474086.2018.1548930. Epub 2018 Nov 27. Review.

PMID:
30444433
27.

Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study.

Khelif A, Saleh MN, Salama A, Portella MDSO, Duh MS, Ivanova J, Grotzinger K, Roy AN, Bussel JB.

Am J Hematol. 2019 Feb;94(2):200-208. doi: 10.1002/ajh.25348. Epub 2018 Nov 29.

28.

Integrating Healthy Eating into Evidence-Based Home Visiting Models: An Analysis of Programs and Opportunities for Dietetic Practice.

Welker EB, Lott MM, Sundermann JL, Bussel JB, Story MT.

J Acad Nutr Diet. 2019 Sep;119(9):1423-1436. doi: 10.1016/j.jand.2018.08.167. Epub 2018 Nov 8. No abstract available.

PMID:
30415895
29.

Avatrombopag.

Bussel JB.

Br J Haematol. 2018 Nov;183(3):342-343. doi: 10.1111/bjh.15568. Epub 2018 Oct 23. No abstract available.

PMID:
30351482
30.

TPO-mimetics for chemotherapy-induced thrombocytopenia: timing matters.

Soff J, Bussel J.

Leuk Lymphoma. 2018 Dec;59(12):2763-2764. doi: 10.1080/10428194.2018.1482545. Epub 2018 Oct 18. No abstract available.

PMID:
30336714
31.

Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag.

Kao YR, Chen J, Narayanagari SR, Todorova TI, Aivalioti MM, Ferreira M, Ramos PM, Pallaud C, Mantzaris I, Shastri A, Bussel JB, Verma A, Steidl U, Will B.

Sci Transl Med. 2018 Sep 12;10(458). pii: eaas9563. doi: 10.1126/scitranslmed.aas9563.

PMID:
30209246
32.

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.

Van Valckenborgh E, Hébrant A, Antoniou A, Van Hoof W, Van Bussel J, Pauwels P, Salgado R, Van Doren W, Waeytens A, Van den Bulcke M.

Arch Public Health. 2018 Sep 6;76:49. doi: 10.1186/s13690-018-0295-z. eCollection 2018.

33.

IVIg and FcγRIIb in kids with ITP: individualizing therapy.

Despotovic JM, Bussel JB.

Blood. 2018 Aug 30;132(9):877-878. doi: 10.1182/blood-2018-07-861690. No abstract available.

PMID:
30166359
34.

Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017.

Goel R, Westblade LF, Kessler DA, Sfeir M, Slavinski S, Backenson B, Gebhardt L, Kane K, Laurence J, Scherr D, Bussel J, Dumler JS, Cushing MM.

Emerg Infect Dis. 2018 Aug;24(8):1548-1550. doi: 10.3201/eid2408.172048. Erratum in: Emerg Infect Dis. 2018 Sep;24(9):1773.

35.

Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.

Kucine N, Al-Kawaaz M, Hajje D, Bussel J, Orazi A.

Br J Haematol. 2019 Apr;185(1):136-139. doi: 10.1111/bjh.15386. Epub 2018 May 16. No abstract available.

PMID:
29767848
36.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
37.

Screening for Wiskott-Aldrich syndrome by flow cytometry.

Chiang SCC, Vergamini SM, Husami A, Neumeier L, Quinn K, Ellerhorst T, Sheppard L, Gifford C, Buchbinder D, Joshi A, Ifversen M, Kleiner GI, Bussel JB, Chandrakasan S, Pesek RD, Pozos TC, Rose MJ, Scurlock AM, Zhang K, Bryceson YT, Bleesing J, Marsh RA.

J Allergy Clin Immunol. 2018 Jul;142(1):333-335.e8. doi: 10.1016/j.jaci.2018.04.017. Epub 2018 May 3. No abstract available.

PMID:
29729304
38.

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.

Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM.

Am J Hematol. 2018 Jul;93(7):921-930. doi: 10.1002/ajh.25125. Epub 2018 May 15.

39.

Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy.

Fassel H, Bussel JB, Roberts SS, Modak S.

J Pediatr Hematol Oncol. 2019 May;41(4):e257-e259. doi: 10.1097/MPH.0000000000001187.

PMID:
29683946
40.

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children.

Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, Hege K, Breakey VR, Rose MJ, Shimano KA, Buchanan GR, Geddis A, Haley KM, Lorenzana A, Thompson A, Jeng M, Neufeld EJ, Brown T, Forbes PW, Lambert MP.

Am J Hematol. 2018 Jul;93(7):882-888. doi: 10.1002/ajh.25110. Epub 2018 May 6.

41.

Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.

Ghanima W, Boiocchi L, Lee CS, Feng X, Geyer JT, Gudbrandsdottir S, Orazi A, Junker P, Bussel JB.

Platelets. 2019;30(2):222-228. doi: 10.1080/09537104.2017.1411586. Epub 2018 Jan 2.

PMID:
29293383
42.

Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.

Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM.

Platelets. 2019;30(2):206-212. doi: 10.1080/09537104.2017.1394451. Epub 2017 Dec 7.

PMID:
29215956
43.
44.

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.

Wong RSM, Saleh MN, Khelif A, Salama A, Portella MSO, Burgess P, Bussel JB.

Blood. 2017 Dec 7;130(23):2527-2536. doi: 10.1182/blood-2017-04-748707. Epub 2017 Oct 17. Erratum in: Blood. 2018 Feb 8;131(6):709.

PMID:
29042367
45.

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

Newland A, Lee EJ, McDonald V, Bussel JB.

Immunotherapy. 2018 Jan;10(1):9-25. doi: 10.2217/imt-2017-0097. Epub 2017 Oct 2. Review.

46.

TPO for ITP in pregnancy.

Bussel JB, Lee EJ.

Blood. 2017 Aug 31;130(9):1073-1074. doi: 10.1182/blood-2017-07-793356. No abstract available.

PMID:
28860321
47.

Imaging and management of fetuses and neonates with alloimmune thrombocytopenia.

Kovanlikaya A, Tiwari P, Bussel JB.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26690. Epub 2017 Jul 4. Review.

PMID:
28675682
48.

Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.

Kuter DJ, Konkle BA, Hamza TH, Uhl L, Assmann SF, Kiss JE, Kaufman RM, Key NS, Sachais BS, Hess JR, Ness P, McCrae KR, Leissinger C, Strauss RG, McFarland JG, Neufeld E, Bussel JB, Ortel TL.

Am J Hematol. 2017 Aug;92(8):730-738. doi: 10.1002/ajh.24759. Epub 2017 Apr 26.

49.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders.

Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.

50.

Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.

Winkelhorst D, Murphy MF, Greinacher A, Shehata N, Bakchoul T, Massey E, Baker J, Lieberman L, Tanael S, Hume H, Arnold DM, Baidya S, Bertrand G, Bussel J, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Ryan G.

Blood. 2017 Mar 16;129(11):1538-1547. doi: 10.1182/blood-2016-10-739656. Epub 2017 Jan 27. Review.

PMID:
28130210

Supplemental Content

Loading ...
Support Center